NCT02041520View on ClinicalTrials.gov

Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2015

Conditions
HIV/AIDS
Interventions
DRUG

omega 3 fatty acids

omega 3 fatty acids will be administered until progression or unacceptable toxicity develops during 6 months follow up.

OTHER

placebo

olive oil in similar presentation of omega 3 fatty acids will be administered until progression or unacceptable toxicity develops during 6 months follow up.

Trial Locations (1)

37320

Instituto Mexicano del Seguro Social, León

All Listed Sponsors
collaborator

Instituto Mexicano del Seguro Social

OTHER_GOV

lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT02041520 - Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients | Biotech Hunter | Biotech Hunter